Drug targeting to the lungs.
D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D002448:Cell Adhesion; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D004317:Doxorubicin / Q000008:administration & dosage; D005290:Ferric Compounds; D017324:Hematoporphyrin Derivative; D006415:Hematoporphyrins / Q000627:therapeutic use; D008168:Lung / Q000378:metabolism*; D008175:Lung Neoplasms / Q000188:drug therapy; D008280:Magnetics; D008353:Mannitol / Q000494:pharmacology; D008833:Microcirculation; D008863:Microspheres; D008954:Models, Biological; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000008:administration & dosage / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy; D009842:Oligopeptides / Q000494:pharmacology; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D013481:Superoxides / Q000378:metabolism
D000806:Angiotensin-Converting Enzyme Inhibitors; D005290:Ferric Compounds; D006415:Hematoporphyrins; D009842:Oligopeptides; D004364:Pharmaceutical Preparations; D013481:Superoxides; C000499:ferric oxide; D008353:Mannitol; D009240:N-Formylmethionine Leucyl-Phenylalanine; D017324:Hematoporphyrin Derivative; C029689:benzoylphenylalanyl-alanyl-proline; D004317:Doxorubicin; D004121:Dimethyl Sulfoxide